Ironwood Pharmaceuticals, Inc.
IRWD
$3.58
-$0.09-2.45%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 123.24% | -60.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 123.24% | -60.91% | |||
| Cost of Revenue | 0.35% | -2.69% | |||
| Gross Profit | 227.19% | -74.05% | |||
| SG&A Expenses | -37.00% | -12.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.06% | -7.69% | |||
| Operating Income | 975.20% | -91.32% | |||
| Income Before Tax | 14,223.52% | -99.33% | |||
| Income Tax Expenses | 793.41% | -90.23% | |||
| Earnings from Continuing Operations | 1,891.43% | -105.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,891.43% | -105.68% | |||
| EBIT | 975.20% | -91.32% | |||
| EBITDA | 912.71% | -90.78% | |||
| EPS Basic | 1,882.14% | -105.67% | |||
| Normalized Basic EPS | 31,037.50% | -99.70% | |||
| EPS Diluted | 1,095.85% | -110.51% | |||
| Normalized Diluted EPS | 30,425.00% | -99.68% | |||
| Average Basic Shares Outstanding | 0.62% | 0.14% | |||
| Average Diluted Shares Outstanding | 2.62% | -8.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||